Showing results (441-450 of 536) with videos related to

Sort By:
Pageof 54
Diabetologia|July 15, 2019
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON studyMegumi Oshima, Min Jun, Toshiaki Ohkuma, et al.
Journal of the American Society of Nephrology : JASN|April 6, 2007
Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trialWouter B A Eijkelkamp, Zhongxin Zhang, Giuseppe Remuzzi, et al.
Diabetologia|February 5, 2017
Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular diseaseStephen P Gray, Jay C Jha, Kit Kennedy, et al.
Cardiovascular Diabetology|January 29, 2026
Activator protein-1 (AP-1) inhibition prevents endothelial to mesenchymal transition in diabetes-associated atherosclerosis: a translational studyAbdul Waheed Khan, Misbah Aziz, Karly C Sourris, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 18, 2018
Ultrasound Combined with Microbubbles Enhances the Effects of Methylprednisolone in Lipopolysaccharide-Induced Human Mesangial CellsPeng-Fei Sun, Tian Tian, Li-Na Chen, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 23, 2020
DIABETIC RETINOPATHY, CLASSIFIED USING THE LESION-AWARE DEEP LEARNING SYSTEM, PREDICTS DIABETIC END-STAGE RENAL DISEASE IN CHINESE PATIENTSLijun Zhao, Honghong Ren, Junlin Zhang, et al.
Renal Failure|March 9, 2021
Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitusHonghong Ren, Lijun Zhao, Yutong Zou, et al.
Journal of Diabetes|July 2, 2020
Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trialHyunju Kim, Dan Wang, John Chalmers, et al.
European Heart Journal|January 27, 2005
Myocardial infarction increases ACE2 expression in rat and humansLouise M Burrell, John Risvanis, Eiji Kubota, et al.
Kidney International|April 1, 2011
An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal functionFrank A Holtkamp, Dick de Zeeuw, Merlin C Thomas, et al.
Pageof 54